Soluble Adhesion Molecules as in vivo Biohumoral Markers of Vascular Cell Activation

Endothelial Dysfunctions in Vascular Disease

Volumn , Issue , 2007, Pages 258-271

  Gianetti, Jacopo ^a   De Caterina, Raffaele ^a,b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adhesion molecules; Endothelial cells; Immunoglobulins; Integrins; Selectins

Indexed keywords

EID: 74349096773     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470988473.ch18     Document Type: Chapter

References (131)

1. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987;238:491-497.
2. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990;8:365-400.
3. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987;48:549-554.
4. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokineinduced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-1211.
5. Wright SD,Weitz JI,Huang AJ, et al. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci USA 1988;85:7734-7738.
6. Kishimoto TK, Larson RS, Corbi AL, et al. The leukocyte integrins. Adv Immunol 1989;46:149-182.
7. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993;91:379-387.
8. Kishimoto TK, Jutila MA, Berg EL, et al. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989;245:1238-1241.
9. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990;50:537-544.
10. Israels SJ, Gerrard JM, Jacques YV, et al. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood 1992;80:143-152.
11. Johnston GI, Cook RG,McEver RP. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989;56:1033-1044.
12. Bonfanti R, Furie BC, Furie B, et al. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989;73:1109-1112.
13. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258:964-969.
14. Lasky LA, Singer MS, Dowbenko D, et al. An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 1992;69:927-938.
15. Graber N, Gopal TV, Wilson D, et al. T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J Immunol 1990;145:819-830.
16. Bochner BS, Luscinskas FW, Gimbrone MA Jr, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-1557.
17. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-554.
18. Spertini O, Luscinskas FW, Kansas GS, et al. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991;147:2565-2573.
19. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983;304:30-34.
20. Williams AF, Barclay AN. The immunoglobulin superfamily - domains for cell surface recognition. Annu Rev Immunol 1988;6:381-405.
21. Dustin ML, Rothlein R, Bhan AK, et al. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-254.
22. Dustin ML, Staunton DE, Springer TA. Supergene families meet in the immune system. Immunol Today 1988;9:213-215.
23. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101.
24. O'Brien KD,Allen MD,McDonald TO, et al.Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993;92:945-951.
25. Rice GE,Munro JM, Bevilacqua MP. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J Exp Med 1990;171:1369-1374.
26. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577-584.
27. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium.Association with expression of VCAM-1. J Immunol 1992;148:1086-1092.
28. Albelda SM, Oliver PD, Romer LH, et al. EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol. 1990;110:1227-1237.
29. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247: 1219-1222.
30. Muller WA, Weigl SA, Deng X, et al. PECAM-1 is required for trans migration of leukocytes. J Exp Med 1993;178:449-460.
31. Stewart RJ,Kashour TS,Marsden PA.Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 1996;156:1221-1228.
32. Gimbrone MA Jr. Vascular Endothelium in Hemostasis and Thrombosis. Edinburgh: Churchill Livingstone; 1986.
33. Gimbrone MA Jr, Bevilacqua M. Vascular endothelium: functional modulation at the blood interface. In: Simionescu N, Simionescu M, eds. Endothelial Cell Biology in Health and Disease. New York: Plenum Press; 1988:255-273.
34. Rosenfeld ME, Tsukada T, Gown AM, et al. Fatty streak initiation in Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1987;7:9-23.
35. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103:181-190.
36. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984;4: 323-340.
37. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
38. Luscinskas FW, Gimbrone MA Jr. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med 1996;47:413-421.
39. Landis RC, Bennett RI, Hogg N. A novel LFA-1 activation epitope maps to the I domain. J Cell Biol 1993;120:1519-1527.
40. Diamond MS, Springer TA. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol. 1993;120:545-556.
41. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
42. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992;116:1292-1300.
43. Hedin U, Bottger BA, Forsberg E, et al. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 1988;107:307-319.
44. Thyberg J, Hedin U, Sjolund M, et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990;10:966-990.
45. Gerszten RE, Luscinskas FW, Ding HT, et al. Adhesion of memory lymphocytes to vascular cell adhesion molecule-1-transduced human vascular endothelial cells under simulated physiological flow conditions in vitro. Circ Res 1996;79:1205-1215.
46. Kuijper PH, Gallardo Torres HI, et al. Platelet-dependent primary hemostasis promotes selectin- and integrinmediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 1996;87:3271-3281.
47. Sterner-Kock A, Braun RK, Schrenzel MD, et al. Recombinant tumour necrosis factor-alpha and plateletactivating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro. Immunology 1996;87:454-460.
48. DeFily DV, Kuo L, Chilian WM. PAF attenuates endothelium-dependent coronary arteriolar vasodilation. Am J Physiol 1996;270:H2094-H2099.
49. Rosenblum WI, Nelson GH, Wormley B, et al. Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 1996;27:709-711.
50. Pigott R, Dillon LP,Hemingway IH, et al. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187:584-589.
51. Gearing AJ,Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-512.
52. Pirozzi G, Terry RW, Labow MA. Murine vascular cell adhesion molecule-1 (VCAM-1) proteins encoded by alternatively spliced mRNAs are differentially targeted in polarized cells. Cell Adhes Commun 1994;2:549-556.
53. Hahne M, Lenter M, Jager U, et al. A novel soluble form of mouse VCAM-1 is generated from a glycolipid-anchored splicing variant. Eur J Immunol 1994;24: 421-428.
54. Schleiffenbaum B, Spertini O, Tedder TF. Soluble Lselectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992;119:229-238.
55. Ley K. Molecular mechanisms of leucocyte rolling and adhesion to microvascular endothelium. Eur Heart J 1993;14(Suppl I):68-73.
56. Hummel V, Kallmann BA,Wagner S, et al. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J Neuropathol Exp Neurol 2001;60:320-327.
57. Ilan N,Mohsenin A, Cheung L, et al. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J 2001;15:362-372.
58. Hattori Y, Kato H, Nitta M, et al. Decrease of L-selectin expression on human CD34 1 cells on freezethawing and rapid recovery with short-term incubation. Exp Hematol 2001;29:114-122.
59. Galis ZS, Khatri JJ.Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-262.
60. Nakamura H,Hino T, Kato S, et al. Tumour necrosis factor receptor gene expression and shedding in human whole lung tissue and pulmonary epithelium. Eur Respir J 1996;9:1643-1647.
61. Sanchez-Garcia J, Atkins C, Pasvol G, et al. Antigendriven shedding of L-selectin from human gamma delta T cells. Immunology 1996;89:213-219.
62. Sano Y, Hirai S, Katayama M, et al. Immunoenzymometric analysis for expression and shedding of intercellular adhesion molecule-1 on human endothelial cells stimulated with cytokines or lipopolysaccharide. Mol Cell Biochem 1994;139:123-130.
63. Garton KJ, Gough PJ, Philalay J, et al. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 2003;278: 37459-37464.
64. Borchers MT, Crosby J, Farmer S, et al. Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol 2001;280:L813-L821.
65. Ferri LE, Swartz D, Christou NV. Soluble L-selectin at levels present in septic patients diminishes leukocyteendothelial cell interactions in mice in vivo: a mechanism for decreased leukocyte delivery to remote sites in sepsis. Crit Care Med 2001;29:117-22.
66. Kitani A, Nakashima N, Izumihara T, et al. Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. J Immunol 1998;161:4931-4938.
67. Evans BJ,McDowall A, Taylor PC, et al. Shedding of lymphocyte function-associated antigen (LFA)-1 in a human inflammatory response. Blood 2006;107:3593-3599.
68. Blann AD, Daly RJ, Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996;92:498-500.
69. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemostasis 1994;72:151-154.
70. De Caterina R, Basta G, Lazzerini G, et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:2646-2654.
71. Peter K, Nawroth P, Conradt C, et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997; 17:505-512.
72. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997;96:4219-4225.
73. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
74. Haim M, Tanne D, Boyko V, et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol 2002;39:1133-1138.
75. Ballantyne CM, Entman ML. Soluble adhesion molecules and the search for biomarkers for atherosclerosis. Circulation 2002;106:766-767.
76. Zouridakis E, Avanzas P, Arroyo-Espliguero R, et al. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004;110:1747-1753.
77. Cominacini L, Fratta Pasini A, Garbin U, et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 1995;38:1122-1124.
78. Bluher M, Unger R, Rassoul F, et al. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia 2002;45:210-216.
79. Basta G, Lazzerini G, Massaro M, et al. Advanced glycation end products (AGEs) activate endothelium via RAGE: a mechanism for amplification of inflammatory responses. Circulation 2002;105:816-822.
80. Schmidt AM, Crandall J, Hori O, et al. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol 1996;92:747-750.
81. Sampietro T, Tuoni M, Ferdeghini M, et al. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation 1997;96:1381-1385.
82. Blann AD, Tse W, Maxwell SJ, et al. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994;12:925-928.
83. Marz W, Scharnagl H, Winkler K, et al. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 2004;110: 3068-3074.
84. De Caterina R, Ghiadoni L, Taddei S, et al. Soluble E-selectin in essential hypertension-a correlate of vascular structural changes. Am J Hypertens 2001;14:259-266.
85. Entman ML, Ballantyne CM. Inflammation in acute coronary syndromes. Circulation 1993;88:800-803.
86. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-172.
87. Liuzzo G,Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.N Engl J Med 1994;331:417-424.
88. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001; 88:10K-15K.
89. Neri-Serneri GG, Abbate R, Gori AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992;86:790-797.
90. Jude B, Agraou B, McFadden EP, et al. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994;90:1662-1668.
91. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-1885.
92. Badwey JA, Karnovsky ML. Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 1980;49:695-726.
93. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
94. Henson PM, Johnston Jr RB. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest 1987;79:669-674.
95. Printseva O, Peclo MM, Gown AM.Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 1992;140:889-896.
96. Poston RN, Haskard DO, Coucher JR, et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992;140:665-673.
97. Mazzone A, De Servi S, Ricevuti G, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;88:358-363.
98. Kukielka GL, Hawkins HK,Michael L, et al. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest 1993;92:1504-1516.
99. Blann AD,Amiral J,McCollum CN.Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. Br J Haematol 1996; 95: 263-265.
100. Shyu KG, Chang H, Lin CC, et al. Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. Chest 1996;109: 1627-1630.
101. Haught WH,Mansour M, Rothlein R, et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996;132:1-8.
102. Ott I, Neumann FJ, Gawaz M, et al. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996;94:1239-1246.
103. Larsen E, Palabrica T, Sajer S, et al. PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15). Cell 1990;63:467-474.
104. Dore M, Simon SI, Hughes BJ, et al. P-selectin- and CD18-mediated recruitment of canine neutrophils under conditions of shear stress. Vet Pathol 1995; 32:258-268.
105. Gawaz MP, Loftus JC, Bajt ML, et al. Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest 1991;88:1128-1134.
106. Spangenberg P, Redlich H, Bergmann I, et al. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemostasis 1993;70:514-521.
107. Ikeda H, Takajo Y, Ichiki K, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995;92:1693-1696.
108. Nagata K, Tsuji T, Todoroki N, et al. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 1993;151:3267-3273.
109. Celi A, Pellegrini G, Lorenzet R, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 1994;91:8767-8771.
110. Gamble JR, Skinner MP, Berndt MC, et al. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science 1990;249:414-417.
111. Wong CS, Gamble JR, Skinner MP, et al. Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci USA 1991; 88:2397-2401.
112. Libby P, Schwartz D, Brogi E, et al. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation 1992;86(Suppl III):47-52.
113. Yasukawa H, Imaizumi T,Matsuoka H, et al. Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. Circulation 1997;95: 1515-1522.
114. Tanaka H, Suzuki A, Schwartz D, et al. Activation of smooth muscle and endothelial cells following balloon injury. Ann NY Acad Sci 1995;748:526-529.
115. Belch JJ, Shaw JW, Kirk G, et al. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 1997;95:2027-2031.
116. Barron MK, Lake RS, Buda AJ, et al. Intimal hyperplasia after balloon injury is attenuated by blocking selectins. Circulation 1997;96:3587-3592.
117. Mulvihill NT, Foley JB, Walsh MA, et al. Relationship between intracoronary and peripheral expression of soluble cell adhesion molecules. Int J Cardiol 2001;77:223-229.
118. Atalar E, Aytemir K, Haznedaroglu I, et al. Platelet and leukocyte deactivation after intracoronary stent placement in patients receiving combined antiplatelet therapy. Clin Appl Thromb Hemost 2001;7:116-121.
119. Kozuka K, Kohriyama T, Nomura E, et al. Endothelial markers and adhesion molecules in acute ischemic stroke-sequential change and differences in stroke subtype. Atherosclerosis 2002;161:161-168.
120. Blann A, Kumar P, Krupinski J, et al. Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. Blood Coagul Fibrinol 1999;10:277-284.
121. Gianetti J, De Caterina M, De Cristofaro T, et al. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. Am Heart J 2001;142:733-739.
122. Pradhan AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule- 1, and the development of symptomatic peripheral arterial disease in men. Circulation 2002;106:820-825.
123. Mossner R, Fassbender K, Kuhnen J, et al. Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques. J Neuroimmunol 1996;65:61-65.
124. Sudhoff T,Wehmeier A, Kliche KO, et al. Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia. Leukemia 1996;10:682-686.
125. Coll-Vinent B, Grau JM, Lopez-Soto A, et al. Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Br J Rheumatol 1997;36:1178-1183.
126. Gattegno L, Bentata-Peyssare M, Gronowski S, et al. Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) and of vascular cell adhesion molecule 1 (VCAM-1) in HIV-1 infection. Cell Adhes Commun 1995;3:179-185.
127. Wenisch C, Myskiw D, Gessl A, et al. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism. J Clin Endocrinol Metab 1995;80:2122-2126.
128. Kaplanski G, Farnarier C, Payan MJ, et al. Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis. Digest Dis Sci 1997;42:2277-2284.
129. Marui A, Fukuda Y, Koyama Y, et al. Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in liver disease, and their changes by treatment with interferon. J Int Med Res 1996;24:258-265.
130. Ashitani J, Mukae H, Ihiboshi H, et al. [Serum-soluble adhesion molecules in patients with idiopathic pulmonary fibrosis and acute respiratory distress syndrome]. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:942-947.
131. Shreeniwas R, Schulman LL, Narasimhan M, et al. Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection. Chest 1996;110:1143-1149.